635 research outputs found

    Novel Identification of LYVE-1 Positive Macrophages in Rheumatoid Synovial Tissue

    Get PDF
    Objective: LYVE-1+ macrophages are observed in a range of cancers, where they play a role in tumour lymphangiogenesis. In rheumatoid arthritis (RA), lymphangiogenesis increases in the early stage of the disease and decreases as it progresses, potentially exacerbating inflammatory cell persistence. We investigated whether LYVE-1+ macrophages were present in RA synovium. Methods: Synovial tissue from RA patients was obtained at joint replacement surgery and immunohistochemistry was performed to visualise LYVE-1+ and CD68+ cells. Results: LYVE-1+ macrophages were present in rheumatoid synovial tissue, the first observation of this kind. Conclusion: Despite the reduction in lymphangiogenesis in chronic RA, LYVE-1 positive macrophages are present and there is a potential role for macrophages in the generation of lymphatic vessels

    Observation of ηcωω\eta_c\to\omega\omega in J/ψγωωJ/\psi\to\gamma\omega\omega

    Get PDF
    Using a sample of (1310.6±7.0)×106(1310.6\pm7.0)\times10^6 J/ψJ/\psi events recorded with the BESIII detector at the symmetric electron positron collider BEPCII, we report the observation of the decay of the (11S0)(1^1 S_0) charmonium state ηc\eta_c into a pair of ω\omega mesons in the process J/ψγωωJ/\psi\to\gamma\omega\omega. The branching fraction is measured for the first time to be B(ηcωω)=(2.88±0.10±0.46±0.68)×103\mathcal{B}(\eta_c\to\omega\omega)= (2.88\pm0.10\pm0.46\pm0.68)\times10^{-3}, where the first uncertainty is statistical, the second systematic and the third is from the uncertainty of B(J/ψγηc)\mathcal{B}(J/\psi\to\gamma\eta_c). The mass and width of the ηc\eta_c are determined as M=(2985.9±0.7±2.1)M=(2985.9\pm0.7\pm2.1)\,MeV/c2c^2 and Γ=(33.8±1.6±4.1)\Gamma=(33.8\pm1.6\pm4.1)\,MeV.Comment: 13 pages, 6 figure

    Observation of the WW-Annihilation Decay Ds+ωπ+D^{+}_{s} \rightarrow \omega \pi^{+} and Evidence for Ds+ωK+D^{+}_{s} \rightarrow \omega K^{+}

    Get PDF
    We report on the observation of the WW-annihilation decay Ds+ωπ+D^{+}_{s} \rightarrow \omega \pi^{+} and the evidence for Ds+ωK+D_{s}^{+} \rightarrow \omega K^{+} with a data sample corresponding to an integrated luminosity of 3.19 fb1^{-1} collected with the BESIII detector at the center-of-mass energy s=4.178\sqrt{s} = 4.178 GeV. We obtain the branching fractions B(Ds+ωπ+)=(1.77±0.32stat.±0.11sys.)×103\mathcal{B}(D^{+}_{s} \rightarrow \omega \pi^{+}) = (1.77\pm0.32_{{\rm stat.}}\pm0.11_{{\rm sys.}}) \times 10^{-3} and B(Ds+ωK+)=(0.87±0.24stat.±0.07sys.)×103\mathcal{B}(D^{+}_{s} \rightarrow \omega K^{+}) = (0.87\pm0.24_{{\rm stat.}}\pm0.07_{{\rm sys.}}) \times 10^{-3}, respectively

    Measurement of proton electromagnetic form factors in e+eppˉe^+e^- \to p\bar{p} in the energy region 2.00-3.08 GeV

    Full text link
    The process of e+eppˉe^+e^- \rightarrow p\bar{p} is studied at 22 center-of-mass energy points (s\sqrt{s}) from 2.00 to 3.08 GeV, exploiting 688.5~pb1^{-1} of data collected with the BESIII detector operating at the BEPCII collider. The Born cross section~(σppˉ\sigma_{p\bar{p}}) of e+eppˉe^+e^- \rightarrow p\bar{p} is measured with the energy-scan technique and it is found to be consistent with previously published data, but with much improved accuracy. In addition, the electromagnetic form-factor ratio (GE/GM|G_{E}/G_{M}|) and the value of the effective (Geff|G_{\rm{eff}}|), electric (GE|G_E|) and magnetic (GM|G_M|) form factors are measured by studying the helicity angle of the proton at 16 center-of-mass energy points. GE/GM|G_{E}/G_{M}| and GM|G_M| are determined with high accuracy, providing uncertainties comparable to data in the space-like region, and GE|G_E| is measured for the first time. We reach unprecedented accuracy, and precision results in the time-like region provide information to improve our understanding of the proton inner structure and to test theoretical models which depend on non-perturbative Quantum Chromodynamics

    First observations of hch_c \to hadrons

    Get PDF
    Based on (4.48±0.03)×108(4.48 \pm 0.03) \times 10^{8} ψ(3686)\psi(3686) events collected with the BESIII detector, five hch_c hadronic decays are searched for via process ψ(3686)π0hc\psi(3686) \to \pi^0 h_c. Three of them, hcppˉπ+πh_c \to p \bar{p} \pi^+ \pi^-, π+ππ0\pi^+ \pi^- \pi^0, and 2(π+π)π02(\pi^+ \pi^-) \pi^0 are observed for the first time, with statistical significances of 7.4σ\sigma, 4.9σ4.9\sigma, and 9.1σ\sigma, and branching fractions of (2.89±0.32±0.55)×103(2.89\pm0.32\pm0.55)\times10^{-3}, (1.60±0.40±0.32)×103(1.60\pm0.40\pm0.32)\times10^{-3}, and (7.44±0.94±1.56)×103(7.44\pm0.94\pm1.56)\times10^{-3}, respectively, where the first uncertainties are statistical and the second systematic. No significant signal is observed for the other two decay modes, and the corresponding upper limits of the branching fractions are determined to be B(hc3(π+π)π0)<8.7×103B(h_c \to 3(\pi^+ \pi^-) \pi^0)<8.7\times10^{-3} and B(hcK+Kπ+π)<5.8×104B(h_c \to K^+ K^- \pi^+ \pi^-)<5.8\times10^{-4} at 90% confidence level.Comment: 17 pages, 16 figure

    A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program

    Get PDF
    The Eurotransplant Senior Program (ESP) has expedited the chance for elderly patients with kidney failure to receive a timely transplant. This current study evaluated survival parameters of kidneys donated after brain death with or without matching for HLA-DR antigens. This cohort study evaluated the period within ESP with paired allocation of 675 kidneys from donors 65 years and older to transplant candidates 65 years and older, the first kidney to 341 patients within the Eurotransplant Senior DR-compatible Program and 334 contralateral kidneys without (ESP) HLA-DR antigen matching. We used Kaplan-Meier estimates and competing risk analysis to assess all cause mortality and kidney graft failure, respectively. The log-rank test and Cox proportional hazards regression were used for comparisons. Within ESP, matching for HLA-DR antigens was associated with a significantly lower five-year risk of mortality (hazard ratio 0.71; 95% confidence interval 0.53-0.95) and significantly lower cause-specific hazards for kidney graft failure and return to dialysis at one year (0.55; 0.35-0.87) and five years (0.73; 0.53-0.99) post-transplant. Allocation based on HLA-DR matching resulted in longer cold ischemia (mean difference 1.00 hours; 95% confidence interval: 0.32-1.68) and kidney offers with a significantly shorter median dialysis vintage of 2.4 versus 4.1 yrs. in ESP without matching. Thus, our allocation based on HLA-DR matching improved five-year patient and kidney allograft survival. Hence, our paired allocation study suggests a superior outcome of HLA-DR matching in the context of old-for-old kidney transplantation.</p
    corecore